NDC 70261-516

Dorzolamide PF

Dorzolamide Pf

Dorzolamide PF is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Imprimisrx Nj. The primary component is Dorzolamide Hydrochloride.

• Product ID: 70261-516_6bb681e9-0fc8-7e5c-e053-2991aa0a7c65
• NDC: 70261-516
• Product Type: Human Prescription Drug
• Proprietary Name: Dorzolamide PF
• Generic Name: Dorzolamide Pf
• Dosage Form: Solution/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2018-01-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: ImprimisRx NJ
• Substance Name: DORZOLAMIDE HYDROCHLORIDE
• Active Ingredient Strength: 20 mg/mL
• Pharm Classes: Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 70261-516-10

10 mL in 1 BOTTLE, DROPPER (70261-516-10)

• Marketing Start Date: 2018-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70261-516-10 [70261051610]

Dorzolamide PF SOLUTION/ DROPS

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-01-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
DORZOLAMIDE HYDROCHLORIDE	20 mg/mL

OpenFDA Data

• SPL SET ID: 6bb681e9-0fc7-7e5c-e053-2991aa0a7c65
• Manufacturer:
  • ImprimisRx NJ
• UNII:
  • QZO5366EW7
• RxNorm Concept Unique ID - RxCUI:
  • 310015

Pharmacological Class

• Carbonic Anhydrase Inhibitor [EPC]
• Carbonic Anhydrase Inhibitors [MoA]